ProQR Therapeutics PRQR
NASDAQ PRQR
$1.63 -0.03 (-1.81%)
At close: Oct 1, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Other Non-Current Liabilities (2017 - 2026)

Updated

ProQR Therapeutics (PRQR) recorded Other Non-Current Liabilities of $247,583 in the quarter ended Jun 30, 2026, down 24.6% from $328,268 a year earlier but up 18.1% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics reported Other Non-Current Liabilities of $264,376, down 47.8% from the prior year.

  • Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -22.7% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Other Non-Current Liabilities came in at $506,534 in the year ended Dec 31, 2024 (+50.6%), $336,414 in the year ended Dec 31, 2023 (-74.7%), $1.33 million in the year ended Dec 31, 2022 (-71.8%) and $4.73 million in the year ended Dec 31, 2021 (+393.5%).
  • Quarterly Other Non-Current Liabilities has ranged from $49,420 in the quarter ended Sep 30, 2024 to $4.57 million in the quarter ended Dec 31, 2021 over the past five years.
  • On a year-over-year basis, Other Non-Current Liabilities rose in four of the last eight quarters, with growth averaging 63.5%.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 590.7% in the quarter ended Sep 30, 2025, against a decline of 94.6% in the quarter ended Sep 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $209,563 (quarter ended Mar 31, 2026), $272,386 (quarter ended Dec 31, 2025) and $341,364 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 ProQR Therapeutics 174.90 Mn -288.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 247,583.07
Mar 31, 2026 209,563.47
Dec 31, 2025 272,386.18
Sep 30, 2025 341,364.09
Jun 30, 2025 328,268.31
Mar 31, 2025 195,650.51
Dec 31, 2024 500,102.65
Sep 30, 2024 49,419.88
Jun 30, 2024 198,147.31
Mar 31, 2024 411,731.11
Dec 31, 2023 334,617.31
Sep 30, 2023 277,590.57
Jun 30, 2023 405,079.87
Mar 31, 2023 636,491.70
Dec 31, 2022 1.29 Mn
Sep 30, 2022 145,191.50
Jun 30, 2022 243,288.92
Mar 31, 2022 313,132.22
Dec 31, 2021 4.57 Mn
Sep 30, 2021 2.67 Mn
API Access

ProQR Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEY